Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for insulin resistance in obese midlife euglycemic women
ACTRN12610000836033Phase 4Completed
- Sponsor
- Monash University
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of metformin in insulin resistance (IR), sponsored by Monash University. Primary endpoint: Change in insulin resistance by HOMA-IR. Started May 2011; status: completed.
02
Drugs
metformin
03
Conditions
insulin resistance (IR)
Beyond the preview
Go deeper on ACTRN12610000836033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000836033.